Trials / Completed
CompletedNCT01344083
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare the efficacy and the safety of T1210 versus Olopatadine eye drops in the topical treatment of seasonal allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T1210 | 2 drops T1210 once a day |
| DRUG | Olopatadine hydrochloride | 2 drops once a day Olopatadine |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-04-28
- Last updated
- 2012-04-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01344083. Inclusion in this directory is not an endorsement.